Pharma Industry News
Printable Version   Email to a friend

Flu Vaccine Recommended for Kids Under Five

Children aged six months to five years should receive vaccinations against influenza, according to a panel of vaccine advisers in a report by Reuters on February 22, 2006.

The decision by the panel - an immunization advisory committee to the Centers for Disease Control and Prevention (CDC) -was welcomed by pediatricians and infectious disease specialists who have sought universal flu vaccination standards.

"Starting with the next influenza season we will not only have children 6 to 24 months but all children up to 5 years of age," Dr Carol J Baker reportedly said, and asked the CDC advisory panel to expand its recommendations. Dr Baker is a pediatrician at Baylor College of Medicine in Houston and president-elect of the National Foundation for Infectious Diseases.

"Vaccination of children 24 to 59 months old will likely reduce the risk of influenza-related complications for all children in this age group, not just those identified with the highest risk of complications from influenza," Dr Anne Schuchat, director of CDC's National Immunization Program, reportedly said.

Dr Baker had hoped that the Advisory Committee on Immunization Practices would recommend improved vaccination of young children with asthma. Instead, she said that the panel had decided to recommend that all children under age five years receive a flu shot, reported MedPage Today.

"The reason for [vaccinating] young children is they have the same amount of hospitalizations and illnesses as older groups, excluding the elderly," Dr Baker reportedly said in a telephone interview. "The infrastructure for vaccinating these young children is in place - the annual visit to the pediatrician."

According to the CDC, influenza was responsible for the deaths of 153 children in the US during the 2003-2004 flu season, making it more lethal than chicken pox, whooping cough and measles combined. Nearly two-thirds of those who died were under age five years, and half were previously healthy, while 43% had asthma, according to MedPage Today.

"The effort of the ACIP to pass this crucial vote represents an important first step in protecting the safety and well-being of children," Richard Kanowitz, president of Families Fighting Flu, reportedly said. Mr Kanowitz's organization reportedly testified to the CDC panel. His four-year-old daughter, Amanda, died from influenza in March 2004.

This Season - 12 Flu Deaths

Flu deaths in the 2005-2006 flu season have remained well below epidemic levels, with only 12 children reported to have died from influenza (although not all deaths are reported). The CDC reported that 13 states have recently had widespread influenza activity, while just under 8% of influenza-like illness tested positive for flu-virus.

In addition to their recommendation to immunize children under five, the panel recommended that siblings, parents and caregivers in the homes of children aged six months to five years should be immunized.

Adult influenza-vaccination rates often fall well short of guidelines in the US. Less than half of the 185 million Americans for whom flu shots are recommended get immunized. Vaccine shortages and distribution troubles complicate delivery. Moreover, fear of lawsuits and production problems have caused many vaccine makers to leave the market.

By expanding the pool of people for whom vaccination is recommended, the CDC hopes that vaccine manufacturers may reenter the market. Dr Baker also noted that vaccinating children may benefit others people, as children are significant spreaders of influenza within any household.

Source: Kids under 5 should get flu shot: panel, Reuters, February 22, 2006.

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


MedNotes
Latest FDA Drug Alerts
October 9, 2008
Audience: Pediatric and primary healthcare professionals, consumers [Posted 10/09/2008] FDA notified healthcare professionals and...
October 7, 2008
Audience: Pulmonary care health professionals and patients[UPDATE 10/07/2008] FDA informed healthcare professionals that FDA has...
October 3, 2008
Audience: Healthcare professionals, consumers [Posted 10/03/2008] FDA notified healthcare professionals of a Class I Recall of...
October 2, 2008
Audience: Physical medicine and rehabilitation specialists, anesthesia healthcare professionals, hospital surgical service...
More...
Latest Drug Information Updates

Akten
Akten (lidocaine hydrochloride) Ophthalmic Gel is a topical, ocular anesthetic formulation for use in ocular procedures that require a topical anesthetic agent.

AdreView
AdreView is a diagnostic radiopharmaceutical agent indicated for use in the detection of rare neuroendocrine tumors in children and adults.

Sancuso
Sancuso (granisetron transdermal system) is an anti-emetic transdermal delivery system indicated for the control of nausea and vomiting in patients receiving moderately and/or highly nausea-inducing chemotherapy.

Nplate
Nplate (romiplostim) is a thrombopoietin mimetic peptibody for the treatment of thrombocytopenia in adult patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP).

Xenazine
Xenazine (tetrabenazine) is a selective and reversible centrally-acting dopamine depleting drug indicated for the treatment of chorea associated with Huntington's disease.

Cleviprex
Cleviprex is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.

Stavzor
Stavzor is delayed-release valproic acid formulated in the EnteriCare enteric soft gelatin capsule delivery system designed to minimize GI adverse events. Stavzor is indicated for the treatment of manic episodes associated with bipolar disorder, adjunctive therapy in multiple seizure types (including epilepsy), and prophylaxis of migraine headaches.

Navstel
Navstel is a balanced salt ophthalmic solution for use as an intraocular irrigation during surgical procedures involving perfusion of the eye.

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

More...